KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares OutstandingShares Repurchased
Ratios

Fulgent Genetics (FLGT) Accumulated Depreciation & Amortization (2016 - 2025)

Historic Accumulated Depreciation & Amortization for Fulgent Genetics (FLGT) over the last 11 years, with Q3 2025 value amounting to $54.2 million.

  • Fulgent Genetics' Accumulated Depreciation & Amortization rose 1035.57% to $54.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $54.2 million, marking a year-over-year increase of 1035.57%. This contributed to the annual value of $51.7 million for FY2024, which is 15.11% up from last year.
  • Per Fulgent Genetics' latest filing, its Accumulated Depreciation & Amortization stood at $54.2 million for Q3 2025, which was up 1035.57% from $58.7 million recorded in Q2 2025.
  • Fulgent Genetics' 5-year Accumulated Depreciation & Amortization high stood at $58.7 million for Q2 2025, and its period low was $12.8 million during Q1 2021.
  • Over the past 5 years, Fulgent Genetics' median Accumulated Depreciation & Amortization value was $46.1 million (recorded in 2023), while the average stood at $39.6 million.
  • In the last 5 years, Fulgent Genetics' Accumulated Depreciation & Amortization soared by 12048.4% in 2022 and then tumbled by 851.49% in 2024.
  • Over the past 5 years, Fulgent Genetics' Accumulated Depreciation & Amortization (Quarter) stood at $19.6 million in 2021, then surged by 120.48% to $43.3 million in 2022, then increased by 19.3% to $51.6 million in 2023, then rose by 0.15% to $51.7 million in 2024, then increased by 4.81% to $54.2 million in 2025.
  • Its Accumulated Depreciation & Amortization stands at $54.2 million for Q3 2025, versus $58.7 million for Q2 2025 and $54.9 million for Q1 2025.